Managers’ transactions announcement according to article 19 MAR

Managers’ transactions announcement according to article 19 MAR

Heidlelberg (pta043/05.10.2020/16:15) – Announcement

1 , Details of the person discharging managerial responsibilities/person closely associated ,

a) , Name , Dr Heikki Lanckriet

2 , Reason for the notification ,

a) , Position/status , Member of the managing body

b) , Initial notification ,

3 , Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ,

a) , Name , 4basebio AG

b) , LEI , 391200H5BDEVHMOV3U10

4 , Details of the transaction(s) ,

a) , Description of the financial instrument, type of instrument , Share

, Identification code , DE000A2YN801

b) , Nature of the transaction , Sale

c) , Price(s) , Volume(s)

, 2.00 EUR , 554,876.00 EUR

d) , Aggregated price , Aggregated volume

, 2.00 EUR , 554,876.00 EUR

e) , Date of the transaction , 30.09.2020 UTC+2

f) , Place of the transaction , Outside a trading venue

5 , Explanation ,

, Sale as part of the takeover bid by Sparta AG. ,

(end)

emitter: 4basebio AG

address: Waldhofer Str. 102, 69123 Heidelberg

country: Germany

contact person: Robert Mayer

phone: +49 171 3876540

e-mail: robert.mayer@4basebio.com

website: investors.4basebio.com

ISIN(s): DE000A2YN801 (share)

stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf; open market in Berlin, Tradegate

[ source: http://www.pressetext.com/news/20201005043 ]